Coral Laboratories Q2 Results
- BSE: 524506
- NSE: -
- ISIN: INE683E01017
- Sector: Biotechnology & Drugs
BSE
569
-3.25 (-0.57%)
-3.25 (-0.57%)Volume320.00
Updated: Mon 12 Oct, 2026 | 11:36:23
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Coral Laboratories Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 26 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 14.23 | 24.80 | -16.77% | 26.23 | -45.77% |
| Depreciation/ Amortization | 0.45 | 0.66 | -0.22% | 0.51 | -11.16% |
| Operating Income | 4.81 | 4.82 | 178.12% | 6.00 | -19.82% |
| Net Income | 5.82 | 5.39 | 126.97% | 6.38 | -8.77% |
| Other Operating Expenses Total | 2.85 | 6.18 | -36.48% | 6.24 | -54.38% |
| Net Income Before Taxes | 7.42 | 6.94 | 99.37% | 8.53 | -13.07% |
| Total Revenue | 19.03 | 29.62 | 1.13% | 32.23 | -40.94% |
| Selling/ General/ Admin Expenses Total | 3.70 | 4.29 | 8.13% | 3.93 | -5.90% |
| Diluted Normalized EPS | 15.58 | 15.08 | 117.01% | 17.86 | -12.76% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.